Literature DB >> 2836554

The global spread and replacement of canine parvovirus strains.

C R Parrish1, P Have, W J Foreyt, J F Evermann, M Senda, L E Carmichael.   

Abstract

Canine parvovirus type 2 (CPV-2) became widespread during 1978 and was reported in many countries during 1978 and 1979. Earlier studies showed that CPV-2 was replaced in the U.S.A. around 1980 by an antigenically and genetically variant virus (CPV-2a). Here we show that CPV-2 was present in the U.S.A., Japan, Belgium and Australia prior to 1980, but that between 1979 and 1982 CPV-2 was replaced by CPV-2a in all of those countries as well as in France and Denmark. Examination of sera collected between 1979 and 1984 from wild coyotes (Canis latrans) in the U.S.A. by an agar gel precipitin assay indicated that the coyotes were originally infected by CPV-2, but that after 1980 the juvenile coyotes were being infected with CPV-2a. The natural global replacement of CPV-2 by CPV-2a over a period of 2 to 3 years indicates that CPV-2a has a strong epidemiological advantage over CPV-2, although the mechanism involved remains to be defined.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2836554     DOI: 10.1099/0022-1317-69-5-1111

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  64 in total

1.  Role of multiple hosts in the cross-species transmission and emergence of a pandemic parvovirus.

Authors:  Andrew B Allison; Carole E Harbison; Israel Pagan; Karla M Stucker; Jason T Kaelber; Justin D Brown; Mark G Ruder; M Kevin Keel; Edward J Dubovi; Edward C Holmes; Colin R Parrish
Journal:  J Virol       Date:  2011-11-09       Impact factor: 5.103

2.  Biological and immunological relations among human parvovirus B19 genotypes 1 to 3.

Authors:  Anna Ekman; Kati Hokynar; Laura Kakkola; Kalle Kantola; Lea Hedman; Heidi Bondén; Matthias Gessner; Claudia Aberham; Päivi Norja; Simo Miettinen; Klaus Hedman; Maria Söderlund-Venermo
Journal:  J Virol       Date:  2007-04-04       Impact factor: 5.103

3.  Canine parvovirus (CPV) vaccination: comparison of neutralizing antibody responses in pups after inoculation with CPV2 or CPV2b modified live virus vaccine.

Authors:  A Pratelli; A Cavalli; V Martella; M Tempesta; N Decaro; L E Carmichael; C Buonavoglia
Journal:  Clin Diagn Lab Immunol       Date:  2001-05

4.  Limited Intrahost Diversity and Background Evolution Accompany 40 Years of Canine Parvovirus Host Adaptation and Spread.

Authors:  Ian E H Voorhees; Hyunwook Lee; Andrew B Allison; Robert Lopez-Astacio; Laura B Goodman; Oyebola O Oyesola; Olutayo Omobowale; Olusegun Fagbohun; Edward J Dubovi; Susan L Hafenstein; Edward C Holmes; Colin R Parrish
Journal:  J Virol       Date:  2019-12-12       Impact factor: 5.103

5.  Genomic typing of canine parvovirus circulating in the State of Rio de Janeiro, Brazil from 1995 to 2001 using polymerase chain reaction assay.

Authors:  A P Costa; J P G Leite; N V Labarthe; R C N Cubel Garcia
Journal:  Vet Res Commun       Date:  2005-11       Impact factor: 2.459

6.  Single Mutations in the VP2 300 Loop Region of the Three-Fold Spike of the Carnivore Parvovirus Capsid Can Determine Host Range.

Authors:  Andrew B Allison; Lindsey J Organtini; Sheng Zhang; Susan L Hafenstein; Edward C Holmes; Colin R Parrish
Journal:  J Virol       Date:  2015-10-28       Impact factor: 5.103

7.  Two parvoviruses that cause different diseases in mink have different transcription patterns: transcription analysis of mink enteritis virus and Aleutian mink disease parvovirus in the same cell line.

Authors:  T Storgaard; M Oleksiewicz; M E Bloom; B Ching; S Alexandersen
Journal:  J Virol       Date:  1997-07       Impact factor: 5.103

8.  Canine and feline parvoviruses preferentially recognize the non-human cell surface sialic acid N-glycolylneuraminic acid.

Authors:  Jonas Löfling; Sangbom Michael Lyi; Colin R Parrish; Ajit Varki
Journal:  Virology       Date:  2013-03-14       Impact factor: 3.616

9.  Evaluation of the antigenic relationships among canine parvovirus type 2 variants.

Authors:  Alessandra Cavalli; Vito Martella; Costantina Desario; Michele Camero; Anna Lucia Bellacicco; Pasquale De Palo; Nicola Decaro; Gabriella Elia; Canio Buonavoglia
Journal:  Clin Vaccine Immunol       Date:  2007-12-26

10.  Detection by PCR of wild-type canine parvovirus which contaminates dog vaccines.

Authors:  M Senda; C R Parrish; R Harasawa; K Gamoh; M Muramatsu; N Hirayama; O Itoh
Journal:  J Clin Microbiol       Date:  1995-01       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.